Switzerland · Delayed Price · Currency is CHF Medartis Holding AG Statistics
Total Valuation
SWX:MED has a market cap or net worth of CHF 983.42 million. The enterprise value is 1.11 billion.
| Market Cap | 983.42M |
| Enterprise Value | 1.11B |
Important Dates
The next confirmed earnings date is Tuesday, August 18, 2026.
| Earnings Date | Aug 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SWX:MED has 12.43 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 12.43M |
| Shares Outstanding | 12.43M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.17% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 9.76% |
| Float | 11.07M |
Valuation Ratios
The trailing PE ratio is 118.06 and the forward PE ratio is 55.32.
| PE Ratio | 118.06 |
| Forward PE | 55.32 |
| PS Ratio | 3.65 |
| PB Ratio | 3.56 |
| P/TBV Ratio | 20.96 |
| P/FCF Ratio | 60.90 |
| P/OCF Ratio | 28.25 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 40.42, with an EV/FCF ratio of 68.65.
| EV / Earnings | 132.78 |
| EV / Sales | 4.12 |
| EV / EBITDA | 40.42 |
| EV / EBIT | 289.97 |
| EV / FCF | 68.65 |
Financial Position
The company has a current ratio of 2.21, with a Debt / Equity ratio of 0.57.
| Current Ratio | 2.21 |
| Quick Ratio | 1.06 |
| Debt / Equity | 0.57 |
| Debt / EBITDA | 5.98 |
| Debt / FCF | 9.79 |
| Interest Coverage | 0.38 |
Financial Efficiency
Return on equity (ROE) is 3.42% and return on invested capital (ROIC) is 0.52%.
| Return on Equity (ROE) | 3.42% |
| Return on Assets (ROA) | 0.35% |
| Return on Invested Capital (ROIC) | 0.52% |
| Return on Capital Employed (ROCE) | 0.60% |
| Weighted Average Cost of Capital (WACC) | 10.13% |
| Revenue Per Employee | 213,866 |
| Profits Per Employee | 6,631 |
| Employee Count | 1,337 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 0.73 |
Taxes
In the past 12 months, SWX:MED has paid 3.45 million in taxes.
| Income Tax | 3.45M |
| Effective Tax Rate | 27.00% |
Stock Price Statistics
The stock price has increased by +5.45% in the last 52 weeks. The beta is 1.26, so SWX:MED's price volatility has been higher than the market average.
| Beta (5Y) | 1.26 |
| 52-Week Price Change | +5.45% |
| 50-Day Moving Average | 84.06 |
| 200-Day Moving Average | 84.62 |
| Relative Strength Index (RSI) | 46.62 |
| Average Volume (20 Days) | 6,920 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SWX:MED had revenue of CHF 269.26 million and earned 8.35 million in profits. Earnings per share was 0.67.
| Revenue | 269.26M |
| Gross Profit | 204.33M |
| Operating Income | 2.85M |
| Pretax Income | 12.79M |
| Net Income | 8.35M |
| EBITDA | 19.57M |
| EBIT | 2.85M |
| Earnings Per Share (EPS) | 0.67 |
Balance Sheet
The company has 32.97 million in cash and 158.12 million in debt, with a net cash position of -125.15 million or -10.07 per share.
| Cash & Cash Equivalents | 32.97M |
| Total Debt | 158.12M |
| Net Cash | -125.15M |
| Net Cash Per Share | -10.07 |
| Equity (Book Value) | 275.87M |
| Book Value Per Share | 22.19 |
| Working Capital | 107.11M |
Cash Flow
In the last 12 months, operating cash flow was 34.82 million and capital expenditures -18.67 million, giving a free cash flow of 16.15 million.
| Operating Cash Flow | 34.82M |
| Capital Expenditures | -18.67M |
| Depreciation & Amortization | 16.73M |
| Net Borrowing | 10.57M |
| Free Cash Flow | 16.15M |
| FCF Per Share | 1.30 |
Margins
Gross margin is 75.89%, with operating and profit margins of 1.06% and 3.10%.
| Gross Margin | 75.89% |
| Operating Margin | 1.06% |
| Pretax Margin | 4.75% |
| Profit Margin | 3.10% |
| EBITDA Margin | 7.27% |
| EBIT Margin | 1.06% |
| FCF Margin | 6.00% |
Dividends & Yields
SWX:MED does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | -0.32% |
| Earnings Yield | 0.85% |
| FCF Yield | 1.64% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SWX:MED has an Altman Z-Score of 2.79 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.79 |
| Piotroski F-Score | 6 |